Is your state getting the full value from its pharmaceutical spend?
$9M+ in supplemental rebates. 10 value-based agreements. 2/2 DUR Board recommendations passed unanimously. Those results came from states like yours.
Your state deserves an independent analytical partner with no divided loyalties. Lyfegen works directly with state Medicaid programs to negotiate stronger manufacturer agreements and build durable programs that generate savings year over year. Contracting strategy, pricing expertise, and claims-based analytics, all serving one interest: yours.
We are not a managed care organization or a PBM. We work for the state.
Rebate optimization:
Rebates beyond the federal floor, negotiated directly with manufacturers on your behalf.
Innovative contracting and managed entry agreements:
The right contract for each drug class, protecting your state from paying for drugs that underperform.
GLP-1 and high-cost drug spend management:
Defensible frameworks for high-growth drug categories before budget exposure becomes unmanageable.
GENEROUS offer evaluation:
A claims-based recommendation before your state responds: accept, retain, or pursue better terms.
Claims-based analytics and budget modeling:
Your claims data turned into savings opportunities and spend forecasts that drive formulary decisions.
Lorem Ipsum:
Lorem Ipsum dolor sit amet consectetur.
“Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse tincidunt sagittis eros. Quisque quis euismod lorem.”
CEO of Helgerson Solutions
Group Former New York State Medicaid Director
Lyfegen Advisory Board
Your state’s own claims data. One interest: your budget and your members.
Real results, real states, on the record.
We work alongside your existing rebate vendor. We step in where they can’t.
